Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier

Sumio Ohtsuki, Tazuru Kikkawa, Shinobu Mori, Satoko Hori, Hitomi Takanaga, Masaki Otagiri, Tetsuya Terasaki

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The "reduced in osteosclerosis" transporter (Roct), which shows decreased expression in the osteosclerosis (oc) mutant mouse, has high homology with rat and human organic anion transporter 3 (OAT3). However, its transport properties and involvement in bone turnover are poorly understood. Here, we examined Roct-mediated transport using a Xenopus laevis oocyte expression system. Roct-expressing oocytes exhibited uptake of [3H]estrone sulfate, [3H]p-aminohippuric acid, [3H]benzylpenicillin, [3H]estradiol 17β-glucronide, [3H]indoxyl sulfate, [14C]indomethacin, [3H]homovanillic acid, [ 3H]cimetidine, [14C]glutarate, [14C]salicylic acid, and [3H]methotrexate. Furthermore, the uptake of [ 3H]benzylpenicillin by Roct coexpressed with Na +-dicarboxylate cotransporter was trans-stimulated by glutarate preloading, and [3H]estrone sulfate uptake showed a similar tendency, suggesting that Roct is a dicarboxylate exchanger. [ 3H]Benzylpenicillin uptake by Roct was inhibited by OAT3 substrates and inhibitors, and by sulfate or glucuronide conjugates, and compounds involved in bone turnover. Roct mRNA is expressed abundantly in the kidney and was also detected in the brain, choroid plexus, and eye. Immunohistochemical analysis revealed that Roct is localized in brain capillary endothelial cells. These results indicate that the transport properties and tissue distribution of Roct are similar to those of OAT3, suggesting that Roct functions as mouse OAT3. Because Roct is expressed in the kidney and at the blood-brain barrier, it may play a role in the excretion of substrates such as conjugates and bone turnover factors.

Original languageEnglish
Pages (from-to)1273-1281
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume309
Issue number3
DOIs
Publication statusPublished - 2004 Jun 1
Externally publishedYes

Fingerprint

Osteosclerosis
Organic Anion Transporters
Blood-Brain Barrier
Membranes
Penicillin G
Bone Remodeling
Glutarates
Oocytes
organic anion transport protein 3
Indican
p-Aminohippuric Acid
Kidney
Homovanillic Acid
Choroid Plexus
Salicylic Acid
Cimetidine
Glucuronides
Xenopus laevis
Brain
Tissue Distribution

ASJC Scopus subject areas

  • Pharmacology

Cite this

Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. / Ohtsuki, Sumio; Kikkawa, Tazuru; Mori, Shinobu; Hori, Satoko; Takanaga, Hitomi; Otagiri, Masaki; Terasaki, Tetsuya.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 309, No. 3, 01.06.2004, p. 1273-1281.

Research output: Contribution to journalArticle

Ohtsuki, Sumio ; Kikkawa, Tazuru ; Mori, Shinobu ; Hori, Satoko ; Takanaga, Hitomi ; Otagiri, Masaki ; Terasaki, Tetsuya. / Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. In: Journal of Pharmacology and Experimental Therapeutics. 2004 ; Vol. 309, No. 3. pp. 1273-1281.
@article{f21deba6b06445fd93eae6a3ca91a755,
title = "Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier",
abstract = "The {"}reduced in osteosclerosis{"} transporter (Roct), which shows decreased expression in the osteosclerosis (oc) mutant mouse, has high homology with rat and human organic anion transporter 3 (OAT3). However, its transport properties and involvement in bone turnover are poorly understood. Here, we examined Roct-mediated transport using a Xenopus laevis oocyte expression system. Roct-expressing oocytes exhibited uptake of [3H]estrone sulfate, [3H]p-aminohippuric acid, [3H]benzylpenicillin, [3H]estradiol 17β-glucronide, [3H]indoxyl sulfate, [14C]indomethacin, [3H]homovanillic acid, [ 3H]cimetidine, [14C]glutarate, [14C]salicylic acid, and [3H]methotrexate. Furthermore, the uptake of [ 3H]benzylpenicillin by Roct coexpressed with Na +-dicarboxylate cotransporter was trans-stimulated by glutarate preloading, and [3H]estrone sulfate uptake showed a similar tendency, suggesting that Roct is a dicarboxylate exchanger. [ 3H]Benzylpenicillin uptake by Roct was inhibited by OAT3 substrates and inhibitors, and by sulfate or glucuronide conjugates, and compounds involved in bone turnover. Roct mRNA is expressed abundantly in the kidney and was also detected in the brain, choroid plexus, and eye. Immunohistochemical analysis revealed that Roct is localized in brain capillary endothelial cells. These results indicate that the transport properties and tissue distribution of Roct are similar to those of OAT3, suggesting that Roct functions as mouse OAT3. Because Roct is expressed in the kidney and at the blood-brain barrier, it may play a role in the excretion of substrates such as conjugates and bone turnover factors.",
author = "Sumio Ohtsuki and Tazuru Kikkawa and Shinobu Mori and Satoko Hori and Hitomi Takanaga and Masaki Otagiri and Tetsuya Terasaki",
year = "2004",
month = "6",
day = "1",
doi = "10.1124/jpet.103.063370",
language = "English",
volume = "309",
pages = "1273--1281",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier

AU - Ohtsuki, Sumio

AU - Kikkawa, Tazuru

AU - Mori, Shinobu

AU - Hori, Satoko

AU - Takanaga, Hitomi

AU - Otagiri, Masaki

AU - Terasaki, Tetsuya

PY - 2004/6/1

Y1 - 2004/6/1

N2 - The "reduced in osteosclerosis" transporter (Roct), which shows decreased expression in the osteosclerosis (oc) mutant mouse, has high homology with rat and human organic anion transporter 3 (OAT3). However, its transport properties and involvement in bone turnover are poorly understood. Here, we examined Roct-mediated transport using a Xenopus laevis oocyte expression system. Roct-expressing oocytes exhibited uptake of [3H]estrone sulfate, [3H]p-aminohippuric acid, [3H]benzylpenicillin, [3H]estradiol 17β-glucronide, [3H]indoxyl sulfate, [14C]indomethacin, [3H]homovanillic acid, [ 3H]cimetidine, [14C]glutarate, [14C]salicylic acid, and [3H]methotrexate. Furthermore, the uptake of [ 3H]benzylpenicillin by Roct coexpressed with Na +-dicarboxylate cotransporter was trans-stimulated by glutarate preloading, and [3H]estrone sulfate uptake showed a similar tendency, suggesting that Roct is a dicarboxylate exchanger. [ 3H]Benzylpenicillin uptake by Roct was inhibited by OAT3 substrates and inhibitors, and by sulfate or glucuronide conjugates, and compounds involved in bone turnover. Roct mRNA is expressed abundantly in the kidney and was also detected in the brain, choroid plexus, and eye. Immunohistochemical analysis revealed that Roct is localized in brain capillary endothelial cells. These results indicate that the transport properties and tissue distribution of Roct are similar to those of OAT3, suggesting that Roct functions as mouse OAT3. Because Roct is expressed in the kidney and at the blood-brain barrier, it may play a role in the excretion of substrates such as conjugates and bone turnover factors.

AB - The "reduced in osteosclerosis" transporter (Roct), which shows decreased expression in the osteosclerosis (oc) mutant mouse, has high homology with rat and human organic anion transporter 3 (OAT3). However, its transport properties and involvement in bone turnover are poorly understood. Here, we examined Roct-mediated transport using a Xenopus laevis oocyte expression system. Roct-expressing oocytes exhibited uptake of [3H]estrone sulfate, [3H]p-aminohippuric acid, [3H]benzylpenicillin, [3H]estradiol 17β-glucronide, [3H]indoxyl sulfate, [14C]indomethacin, [3H]homovanillic acid, [ 3H]cimetidine, [14C]glutarate, [14C]salicylic acid, and [3H]methotrexate. Furthermore, the uptake of [ 3H]benzylpenicillin by Roct coexpressed with Na +-dicarboxylate cotransporter was trans-stimulated by glutarate preloading, and [3H]estrone sulfate uptake showed a similar tendency, suggesting that Roct is a dicarboxylate exchanger. [ 3H]Benzylpenicillin uptake by Roct was inhibited by OAT3 substrates and inhibitors, and by sulfate or glucuronide conjugates, and compounds involved in bone turnover. Roct mRNA is expressed abundantly in the kidney and was also detected in the brain, choroid plexus, and eye. Immunohistochemical analysis revealed that Roct is localized in brain capillary endothelial cells. These results indicate that the transport properties and tissue distribution of Roct are similar to those of OAT3, suggesting that Roct functions as mouse OAT3. Because Roct is expressed in the kidney and at the blood-brain barrier, it may play a role in the excretion of substrates such as conjugates and bone turnover factors.

UR - http://www.scopus.com/inward/record.url?scp=2442720194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442720194&partnerID=8YFLogxK

U2 - 10.1124/jpet.103.063370

DO - 10.1124/jpet.103.063370

M3 - Article

VL - 309

SP - 1273

EP - 1281

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -